About
Technology
Issues
FAQ
Links
Official Page
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.